1
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Methods of utilizing arylpiperazine derivatives. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, April 30, 2013: US08431570 (1 worldwide citation)

The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


2
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, May 29, 2012: US08188076 (1 worldwide citation)

The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


3
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra: Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, August 21, 2012: US08247563 (1 worldwide citation)

The present invention provides novel indanone derivatives which can be advantageously used for treating and/or preventing of a medical condition for which inhibition of a cholinesterase is desired.


4
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Methods of utilizing arylpiperazine derivatives. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, October 14, 2014: US08859552

The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.


5
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Methods of utilizing arylpiperazine derivatives. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, June 11, 2013: US08461154

The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


6
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu P Mohapatra, Seema Rani Bhat: Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, August 21, 2012: US08247420

The present invention provides novel quinolinone derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression.


7
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Sureshbabu Dadiboyena, Kouacou Adiey: Compositions, synthesis, and methods of utilizing quinazolinedione derivatives. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, November 5, 2013: US08575185

The present invention provides quinazolinedione derivatives of Formulae Ia and Ib, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, depression and dementia.


8
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Compositions, synthesis, and methods of using piperazine based antipsychotic agents. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, June 26, 2012: US08207163

The present invention provides novel piperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


9
Rong Chang Liang, Scott C J Tseng, Zarng Arh George Wu, HongMei Zang, Hsiao Ken Chuang: Electrophoretic display and novel process for its manufacture. SiPix Imaging, Albert P Halluin, Viola T Kung, Howrey Simon Arnold & White, September 7, 2004: US06788449 (267 worldwide citation)

This invention relates to an electrophoretic display comprising cells of well-defined shape, size and aspect ratio which cells are filled with charged pigment particles dispersed in a solvent, and novel processes for its manufacture.


10
Gregory P Winter, Lutz Riechmann, William D Huse, Joseph A Sorge, Richard A Lerner: Method for tapping the immunological repertoire. Scripps Research Institute, Medical Research Council, Stratagene, Albert P Halluin, Viola T Kung, Howrey Simon Arnold & White, September 18, 2001: US06291158 (99 worldwide citation)

The present invention relates to a method for isolating from the immunological gene repertoire a gene coding for a receptor having the ability to bind a preselected ligand. Receptors produced by the gene isolated by the method, particularly catalytic receptors, are also contemplated.



Click the thumbnails below to visualize the patent trend.